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A novel optical tracer for VMAT2 
applied to live cell measurements 
of vesicle maturation in cultured 
human β-cells
stevan pecic  1, Nenad Milosavic2, Gina Rayat3, Antonella Maffei  4 & paul e. Harris  4
the islet β-cells integrate external signals to modulate insulin secretion to better regulate blood 
glucose levels during periods of changing metabolic demand. the vesicular monoamine transporter 
type 2 (VMAT2), an important regulator of CNS neurotransmission, has an analogous role in the 
endocrine pancreas as a key control point of insulin secretion, with additional roles in regulating β-cell 
differentiation and proliferation. Here we report on the synthesis and biological characterisation of a 
fluorescent ligand for VMAT2 suitable for live cell imaging. Staining for VMAT2 and dopamine in live 
β-cell cultures show colocalisation in specific vesicles and reveal a heterogeneous population with 
respect to cell size, shape, vesicle number, size, and contents. Staining for VMAT2 and zinc ion, as a 
surrogate for insulin, reveals a wide range of vesicle sizes. Immunohistochemistry shows larger β-cell 
vesicles enriched for proinsulin, whereas smaller vesicles predominantly contain the processed mature 
insulin. In β-cell cultures obtained from nondiabetic donors, incubation at non-stimulatory glucose 
concentrations promotes a shift in vesicle diameter towards the more mature insulin vesicles at the 
expense of the larger immature insulin secretory vesicle population. We anticipate that this probe 
will be a useful reagent to identify living β-cells within complex mixtures for further manipulation and 
characterisation.
The islet β-cells integrate external signals to modulate insulin secretion to fine tune blood glucose levels during 
periods of changing metabolic demand1. In addition to glucose, fatty acids and gut derived peptides, net insu-
lin production is regulated by a number of other molecules, including a number of classical neurotransmitters 
including dopamine. We and others have shown that β-cell secreted dopamine (DA) mediates a glucose stimu-
lated insulin secretion (GSIS) inhibitory circuit in human β-cells2–4. We demonstrated that islet β-cells co-secrete 
insulin and dopamine in response to glucose stimulation, both in vivo and in vitro, and that dopamine down 
regulates insulin secretion via dopamine type 2 like-receptors (D2R) expressed by β-cells. In this circuit, DA, syn-
thesised de novo or imported by dopamine (reuptake) transporter (DAT), is stored in β-cell vesicles by the action 
of the vesicular monoamine transporter type 2 (VMAT2). These insulin granules also contain D2R. During GSIS, 
DA and insulin are released and D2R is delivered to the cell surface where it binds DA to down-regulate insulin 
secretion by an autocrine mechanism5. Thus, in the pancreas, VMAT2 is a central point for control of insulin 
secretion, a function analogous to its role in the CNS of regulating monoamine neurotransmission6.
VMAT2 is a tissue restricted marker of β-cells in the pancreas. Previously, VMAT2 quantification in living 
cells had only been performed at the population level in situ by positron emission tomography (PET)7–9, or by 
indirect methods relying on non-specific fluorescent substrates of vesicular monoamine transporters10,11. PET 
imaging of human β-cells in situ relies on [18 F] or [11 C] labelled dihydrotetrabenazine. Dihydrotetrabenazine 
((+) DTBZ) is a VMAT2 ligand with a nanomolar affinity constant12. We set out to develop a (+) DTBZ based 
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VMAT2 ligand with a fluorescent reporter suitable for live cell imaging and tested its utility in morphometric 
studies of β-cell vesicles.
Results
physiochemical characterisation. The synthetic strategy for the probe was based on the structures of 
the specific VMAT2 inhibitor dihydrotetrabenazine ((+) DTBZ), the validated, subnanomolar Kd PET probe 
for VMAT2, 18F-fluoropropyl dihydrotetrabenazine (FPDTBZ), the radiosynthetic precursor of 18F-FPDTBZ, 
(+)-9-O-Desmethyl-α-Dihydrotetrabenazine (Fig. 1A,B).
The probe synthesised had a molecular weight of 538 g/mol by ESI-MS (m/z + 1 = 539). Characterisation 
of absorption and emission spectra of dansyl (+)DTBZ ((+) DDTBZ) revealed maxima at λex = 339 nm and 
λem = 523 (Fig. 2). As expected, the excitation and emission maxima were similar to the parent fluorescent 
reporter dansyl chloride. Neither the radiosynthetic precursor nor DTBZ showed significant fluorescence at 
523 nm at the concentrations tested (≤100 µM).
(+) DDTBZ colocalises with and binds preferentially to VMAT2 positive cells. To demonstrate the 
specificity of (+) DDTBZ to VMAT2, various concentrations of (+) DDTBZ were added to live cultures of HEK 
293 transfected with the VMAT2-mCherry fusion protein. Cells were then imaged for (+) DDTBZ fluorescence 
signal, followed by VMAT2-mCherry fluorescence at the indicated wavelength (Fig. 3).
We found (+) DDTBZ signal significantly overlapped with mCherry VMAT2 signal. Next, we extended 
the studies of (+) DDTBZ binding to three other non-beta cell lines to characterize the possible specific and 
Figure 1. Structures and Synthesis of (+) DDTBZ. Panel 1A Dihydrotetrabenazine based structures. (1) 
Dihydrotetrabenazine (2-hydroxy-3-isobutyl-9-methoxy-10 -methoxy-1,2,3,4,6,7,- hexahydro-11bH-
bezo[alpha]-quinolizine) ((+) DTBZ). (2) (+)-2-Hydroxy-3-isobutyl-9-(3-fluoropropoxy)-10-methoxy-
1,2,3,4,6,7-hexahydro-11bH-benzo[a]quinolizine ((+) FPDTBZ). (3) 2H-Benzo[a]quinolizine-2,9-diol, 
1,3,4,6,7,11b-hexahydro-10-methoxy-3-(2-methylpropyl)-, (2 R,3 R,11bR) ((+) Desmethyl DTBZ). Panel 1B 
Synthesis of 2-hydroxy-3-isobutyl-9-methoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-8-yl 
5-(dimethylamino)naphthalene-1-sulfonate ((+) DDTBZ) reagents and conditions: (a) 5-(dimethylamino)
naphthalene-1-sulfonyl chloride (dansyl chloride), N,N-dimethylpyridin-4-amine (DMAP), dichloromethane 
(DCM), 0 °C, RT, room temperature.
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non-specific binding of the probe. HEK 293 cells, the untransfected counterparts of HEK-DAT mCherry-VMAT2 
cells studied above, PANC1 cells, derived from a human pancreatic carcinoma of ductal cell origin and 5637 cells, 
derived from a human uroepithelial carcinoma were seeded into coverglass chambers slides and allowed to attach 
and proliferate. HEK 293, PANC1 and 5637 cells were incubated with (+) DDTBZ, LysoTracker Red and Nuclear 
Mask Deep Red and the cells imaged at the indicated wavelengths (Fig. 4). The collection of DDTBZ fluorescent 
signal was performed under a higher gain setting relative to that used for imaging, LysoTracker Red and Nuclear 
Mask Deep Red signals, to allow visualization of possibly weak signals. We found that (+) DDTBZ fluorescence 
in HEK 293 cells was greatest in the nuclear region and perinuclear regions of the cells, but not found in vesicles. 
LysoTracker red staining of HEL 293 cells show few vesicles. Similarly (+) DDTBZ fluorescence in PANC-1 cells 
was associated with the nucleous and some uncharacterized cytoplasmic structures. LysoTracker red staining of 
PANC-1 cells show many more small vesicles than HEK 293, but (+) DDTBZ fluorescence was not associated 
with these vesicles. The 5637 cell line showed abundant vesicular staining with (+) DDTBZ, as well as perinu-
clear and nuclear staining. LysoTracker red staining of 5637 cells show many more small vesicles than PANC-1 
cells. (+) DDTBZ vesicular fluorescence was associated with a partially overlapping set of Lysotracker red avid 
vesicles, but some vesicles stained only with (+) DDTBZ. Using the greyscale values from the cell images, the 
vesicular staining in 5637 cells was 2–5 times the cytoplasmic background depending on the location of the ves-
icles. Examination of the public gene expression databases revealed that HEK 293 cell do not express SLC18A2 
transcripts (a.k.a VMAT2)13, while PANC-1 cells express SLC18A2 transcripts weakly (i.e. in the bottom 0.3% of 
the >40 k different genes probed)14. In a previous report, 5637 cells were used to deposit an extracellular matrix 
on cover slips suitable for human beta cell culture15. 5637 cells have also been used a source of secreted colony 
stimulating factors16, but were not recognized for expression of VMAT2. The vesicular staining by (+) DDTBZ 
correctly identified 5637 cells as expressing SLC18A2 transcripts17.
Figure 2. Excitation and emission spectra of (+) DDTBZ. Stock solutions of (+) DDTBZ in DMSO were 
diluted to 20 uM and their excitation-emission spectra recorded. Results are diluent (PBS, 1% DMSO) 
background subtracted.
Figure 3. (+) DDTBZ binding colocalises with mCherry-VMAT2 and binds preferentially to VMAT2 
transfected HEK 293 cells. Successive z focal planes of a HEK-DAT mCherry-VMAT2 cell stained with (+) 
DDTBZ (Panel A–H). (+) DDTBZ (30 µM) was added to cell cultures, cells were incubated and then washed 
and imaged (excitation at 385 nm, emission collected at 465–525 nm) (Panel A). The VMAT2-mCherry fusion 
protein was visualised at 645–720 nm (Panel B). Panel C is the colocalisation plot for the data collected in Panels 
A and B. - The z axis of Panel C is the heat map scoring of the number of pixels with equivalent intensities. 
The pixel intensities in each channel laying within the region of interest (white box) region of interest were 
significantly correlated (p = 0.86) and are shown in white in Panel D. the merged pseudocolour image of Panels 
A (green) and B (red) and region of interest data from Panel C (within white box). Scale bar represents 10 µm.
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To better quantify the displaceability and saturability of (+) DDTBZ binding to cellular VMAT2, we repeated the 
binding experiments in 96 well plates suitable for fluorescent imaging of HEK-DAT mCherry-VMAT2 and untrans-
fected HEK 293 cells. Cell cultures were incubated in (+) DDTBZ with and without (±) DTBZ, washed and the 
bound fluorescence signal quantified (Fig. 5). Binding of (+) DDTBZ was saturable, and displaceable by increasing 
concentrations of (±) DTBZ in HEK -DAT, mCherry-VMAT2 transfected cells. Using this platform, the HEK-DAT 
mCherry VMAT2 cells bound >50 times more (+) DDTBZ relative to the control, untransfected HEK 293 cells.
VMAT2 and dopamine colocalise in the vesicles of cultured β-cells. We previously demonstrated 
that β-cells are the primary storage site for dopamine in the pancreas18. Both insulin and VMAT2 immunoreac-
tivity colocalise almost exclusively in the β-cells of human islets19,20, and human islets release both insulin and 
dopamine in response to glucose challenge2. We took advantage of the two-dimensional human β-cell culture 
system described by Phelps et al.15 to examine the expression of VMAT2 in dissociated human and porcine islet 
cell cultures. Since (+) DDTBZ excitation spectrum peaks at near UV wavelengths, we were able to use other 
fluorescent probes for imaging the same cultures. NeuroSensor 521 is a fluorescent turn-on sensor that allows 
for the selective recognition and sensing of norepinephrine and dopamine in live cells21. Since islet β-cells do 
not express Dopamine-Beta-Hydroxylase responsible for the transformation of dopamine into norepinephrine22 
and analysis of human islet culture supernatants by HPLC coupled with electrochemical detection demonstrate 
dopamine but fail to show significant amounts of norepinephrine (unpublished observations), we concluded that 
NeuroSensor 521 would enable us to visualise the presence of vesicular dopamine (DA) in these cultures. β-cell 
cultures were also stained with LysoTracker® Red DND-99, a fluorescent probe specific for acidic organelles 
such as lysosomes as well as the insulin containing β-cell vesicles which are reported to have a resting pH around 
5.9–6.223. In Fig. 6 representative images of cells stained with (+) DDTBZ, NeuroSensor 521 and LysoTracker 
Red DND-99 are presented.
Merged pseudocolour images of (+) DDTBZ, NeuroSensor 521 and LysoTracker® Red DND-99 stained cultures 
revealed a morphologically heterogeneous population of cells with respect to cell shape, degree of probe binding and 
vesicle size. (+) DDTBZ, NeuroSensor 521, Lysotracker red binding represented largely overlapping sets, but many 
vesicles showed strong binding of only one or two of the fluorescent probes. Not all cells bound (+) DDTBZ and 
NeuroSensor 521 and are likely to represent the non-β-cell constituents of the islet cultures (see Supplemental Fig. S1).
Figure 4. Vesicular binding of (+) DDTBZ distinguishes VMAT2 positive cells from the non-specific binding 
pattern in VMAT2 negative cells. HEK293, PANC1 and 5637 cells were stained with (+) DDTBZ, Nuclear Mask 
Deep Red (NMDR) and Lysotracker Red DND-99  (LT). The (+) DDTBZ signal was acquired with a 495BP30 
filter and is shown in green in the pseudocolour merged images at right. NMDR and LT signals were imaged 
together in a 655 to 710 nm window and are shown in red in the pseudocolour merged images at right. Scale bar 
represents 10 microns.
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Murine islets have been reported to express lower amounts of VMAT2 relative to its’ expression in human 
islets24. We examined the binding pattern of (+) DTBBZ in cultures of βTC-6, an insulin secreting mouse cell line 
derived from transgenic B6D2 mice harboring the SV40 T-antigen driven by the upstream enhancer-promoter 
region of the rat insulin II gene25. We found that (+) DDTBZ staining (Supplemental Fig. S2) was heterogenous 
as we could identify cells clusters devoid of (+) DDTBZ positive cells (Supplemental Fig. S2, upper panel), cell 
clusters containing both (+) DDTBZ positive and negative cells (Supplemental Fig. S2, lower panel) and clusters 
composed of almost entirely of (+) DDTBZ positive cells. Within the group of βTC-6 cells and cell clusters stain-
ing positively with (+) DDTBZ, the number of (+) DDTBZ positive vesicles per cell (mean = 2.2 versus 208) as 
well as the vesicle diameters (mean = 512 nm versus 699 nm) were significantly (p < 0.05, two tailed test) smaller 
than vesicles imaged in (+) DDTBZ positive human islet cells.
To demonstrate that beta cell vesicular binding of (+) DDTBZ was displacable, islet cell cultures treated with 
30 µM (+) DDTBZ and an 8 fold molar excess of racemic (±) DTBZ (corresponding to a 4 fold molar excess of 
(+) DTBZ). Vesicles in these cultures showed an average 50% reduction in average vesicular fluorescent intensity 
(see Supplemental Fig. S3).Next, we examined cultures of dispersed porcine islet cells treated with (+) DDTBZ, 
NeuroSensor 521 and LysoTracker® Red DND-99 (see Supplemental Fig. S4). Similar results to human islets 
cultures were obtained.
VMAT2 and Zinc colocalise in the vesicles of cultured β-cells. The role of zinc in the formation of 
mature insulin secretory vesicles has been reviewed by Li26. Briefly, translated preproinsulin in the lumen of the 
rough ER is cleaved to form proinsulin. Proinsulin is transported to the trans-Golgi network for packaging into 
secretory granules where it is converted to insulin by selective cleavage of the C-peptide. Insulin is initially found 
in its monomeric form, but as it accumulates, a dimeric conformation is favored. Intracellular Zn+2 is transported 
via ZnT8 into the vesicles where it facilitates the formation of a 2-Zn+2-trimer of dimers (i.e. hexameric insulin) in 
a process reported to be stabilised by the presence of dopamine27. On this basis, we have used intravesicular Zn+2 
combined with the presence of VMAT2 as a surrogate marker for insulin containing vesicles.
Fluorescent zinc probes have been used to image intracellular Zn+2 in β-cells28,29 but not at the resolution 
levels used in current experiments. We selected FluoZin-3, AM, an on-off selective fluorescent Zn+2 probe30. The 
probe is prepared as an acetoxymethy ester which enhances cell permeability, yet de-esterifies intracellularly as an 
aid to maintenance of the signal. Merged pseudocolour images of (+) DDTBZ, FluoZin-3, AM and LysoTracker® 
Red DND-99 stained cultures (Fig. 7) revealed a morphologically heterogeneous population of cells with respect 
to cell shape, degree of probe binding and vesicle size. (+) DDTBZ, FluoZin-3, and LysoTracker Red triple posi-
tive vesicles could be identified in a majority of cells. In addition, we could identify at least three subsets of triple 
positive cells; 1) Cells containing mostly larger vesicles (diameters 600–2000 nm) (Fig. 7, row 1), 2) Cells with 
mixed large and small vesicles (Fig. 7, row 2), and 3) cells containing mostly smaller vesicles (diameters ≤480 nm) 
(Fig. 7, row 3). Some cells showed (+) DDTBZ positive vesicles, yet only a few vesicles binding FluoZin-3 and a 
weak cytoplasmic signal in the green channel (Fig. 7, row 4).
Lastly, common features of the β-cell vesicles visualised by (+) DDTBZ were the occasional apparent entrain-
ment of vesicles within the β-cell cytoplasm (e.g. Fig. 7, row 1), a wide range of vesicle diameters, and perinuclear 
regions relatively void of vesicles staining with (+) DDTBZ (e.g. Fig. 7, row 1 and 2) compared to adjacent areas. 
We speculated that the larger vesicles might be the newly formed vesicles enriched for proinsulin polypeptide and 
the smaller vesicles enriched with the mature processed form insulin. Human β-cells cultures were fixed and pro-
cessed for immunohistochemistry with anti-VMAT2 antibodies and anti-proinsulin or anti-insulin antibodies. 
Figure 5. Specificity, Displaceability and Saturability of (+) DDTBZ binding. HEK-DAT-mCherryVMAT2 
or untransfected HEK 293 cells were cultured in 96 well glass bottom black plastic plates. (+) DDTBZ (20 µM) 
was added to the cultures and the bound fluorescence quantified. Results are the averages of three independent 
experiments. The IC50 (DDTBZ by ((±) DTBZ ≈ 7 µM) was estimated graphically (dotted line). Error bars are 
the standard error of the mean.
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Confirming our previous findings using formaldehyde fixed paraffin embedded whole pancreas tissue19, we 
found that VMAT2 and insulin immunoreactivity colocalised in the cytoplasm of fixed β-cells (see Supplemental 
Fig. S5). Additionally we found that larger VMAT2 positive vesicles were indeed enriched for proinsulin polypep-
tide (see Supplemental Fig. S6).
To better understand the relationship between (+) DDTBZ binding and the morphology of human β-cells in 
this culture system, we stained the β-cells with (+) DDTBZ and substituted FluoZin-3 AM with BODIPY™ FL 
C5-Ceramide complexed to BSA (see Supplemental Fig. S6). BODIPY™ FL C5-Ceramide is a well characterised 
stain for the trans-Golgi network31. We observed that the cytoplasmic voids of (+) DDTBZ positive vesicles 
represented areas containing the trans-Golgi network as revealed by the binding of BODIPY™ FL C5-Ceramide. 
Apparent nascent secretory vesicles, as judged by their intimate association with the Golgi membranes, were 
visible. Of these nascent vesicles, only a minority retained (+) DDTBZ or LysoTracker Red. (see Supplemental 
Fig. S6).
Figure 6. (+) DDTBZ, NeuroSensor 521 and LysoTracker® Red DND-99 staining of live human islet 
cell cultures identifies VMAT2 positive, monoamine positive, acidic vesicles in a morphologically diverse 
population of cells. Cell cultures were stained with the three probes and imaged in their corresponding 
channels. These are representative images from identical experiments performed on two different donors 991 
and 025. The merged pseudocolour image (right panels) represents the three grey scale images, (+) DDTBZ 
(blue channel), NeuroSensor 521 (green channel) and Lysotracker Red DND-99 (red channel) translated to an 
RGB image. Scale bar represents 10 µm.
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Incubation of cultured β-cells in low glucose is accompanied by a reduction in average insulin 
vesicle size. In vitro, islets, β-cells, and β-cell lines are often cultured under growth/survival permissive mod-
erate glucose concentrations (10–12 mM Glucose). For measurements of insulin secretion from these cultures, 
however, the normal culture media is often exchanged with a lower glucose concentration basal medium that does 
not trigger insulin secretion and the cultures are allowed to “rest” for various intervals, nominally to allow the 
accumulation of fully processed mature insulin secretory vesicles. Once stimulated, the amplitudes of secretory 
responses are greater relative to cultures that have not been preincubated in low glucose basal medium. We tested 
the insulin secretion characteristics of the two-dimensional dispersed human β-cell culture system. The β-cell cul-
tures were incubated normally in 12 mM glucose culture medium for five days and then tested for glucose stim-
ulated insulin secretion (GSIS), or cultured for an additional two in culture medium containing 4 mM Glucose. 
Cultured β-cells were washed and then rested for 60 minutes at 37 C in a 2.5 mM glucose buffer. This media was 
replaced with 1 ml of either 2.5 or 16 mM glucose buffer and incubated again for 60 minutes at 37 C. The insulin 
concentration in each solution was measured by enzyme linked immunoassay and then normalized to the DNA 
Figure 7. (+) DDTBZ, FluoZin™-3 AM zinc probe and Lysotracker staining identify a morphologically 
heterogeneous population of cells with VMAT2 positive, Zinc positive acidic vesicles in live human islet 
cultures. A merged pseudocolour image (right panels) represents the three grey scale images, (+) DDTBZ (blue 
channel), FluoZin-3 AM (green channel) and Lystotracker Red DND-99 (red channel) translated to an RGB 
image These are representative images from identical experiments performed on three donors (141, 212 and 
556). Scale bar represents 10 µm.
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content of the well. We next calculated a stimulation index comparing the insulin secreted at 16 mM Glucose to 
the insulin secreted at 2.5 mM Glucose (Fig. 8).
There was a statistically significant increase (p < 0.05 paired t test) in the insulin secretion rate when 2.5 mM 
(basal) and 16 mM glucose (stimulated) were compared. The stimulation indices for all conditions were about 
1.3 ± 0.2. The insulin secretion rates were less on day 7 (following 48 hr incubation in culture media supple-
mented with 4 mM glucose) relative to day 7.
To demonstrate the utility of identifying and quantifying VMAT2 positive, zinc positive vesicles in living 
β-cell cultures, we prepared β-cell cultures from two nondiabetic control donors and one donor diagnosed with 
type 2 diabetes mellitus (T2D). Cell cultures were either maintained in high glucose (12 mM) media or incubated 
in low glucose (2.5 mm) media for one-hour prior to staining with (+) DDTBZ and FluoZin-3. Next, the cell 
cultures were imaged, the (+) DDTBZ and FluoZin-3 channels combined and the diameters of (+) DDTBZ and 
FluoZin-3 double positive β-cell vesicles quantified by the OpenCFU software (see Supplemental Fig. S8). During 
the one hour 2.5 mM low glucose incubation period, we estimated that in control β-cells, the mean vesicle diam-
eter is significantly reduced by about 100 nm (two-tailed t-test, p < 0.0001), relative to the diameters measured 
under the 12 mM glucose culture conditions (mean vesicular diameter = 734 nm) (Fig. 9, Left Panel). Vesicle 
diameters were not reduced by 2.5 mM glucose culture in β-cells obtained from the donor diagnosed with T2D, 
rather a significant increase in mean vesicular diameter, from 688 nm to 724 nm (two-tailed t-test,p < 0.0001) was 
observed (Fig. 9, Right Panel).
Discussion
We report on the synthesis, physiochemical and biological characterisation of a fluorescent ligand for VMAT2 
and demonstrate its utility in an application relevant to β-cell biology. (+) DDTBZ differs from previous optical 
tracers used in CNS neurotransmission studies. These tracers, namely fluorescent false neurotransmitters10,11 and 
dansyl dopamine32, are nonselective VMAT1 and VMAT2 substrates. Future studies should include a side by side 
Figure 8. Insulin secretion characteristics of β-cell cultures. Panel A β-cell cultures were cultured in regular 
media containing 12 mM glucose for 5 days (Hi Gluc), then assayed for glucose stimulated insulin secretion 
(GSIS). Panel B β-cell cultures were cultured in regular media containing 12 mM glucose for 5 days, transferred 
to media supplemented to 4 mM glucose (Lo Gluc), then assayed for GSIS. The insulin content of supernatants 
was measured by ELISA and normalized to the DNA content of the well. Asterisks show statistical significance 
(p < 0.05, paired t test) of the difference between basal and stimulated insulin secretion. Donor RRID appears 
within each symbol.
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comparison of these optical tracers in both the β-cell and neuronal cell cultures to understand their similarities 
and differences.
The application selected to showcase the utility of (+) DDTBZ was a morphometric study of insulin secretory 
vesicles in cultured β-cells. Our principle findings are summarised as follows; (1) (+) DDTBZ and dopamine 
staining reveal a morphologically heterogeneous population, in terms of cell size, shape, vesicle number, size and 
contents, (2) VMAT2 and Zn+2 colocalise in wide range of β-cell acidic vesicle sizes, (3)The larger β-cell vesicles 
are enriched for proinsulin, whereas the smaller vesicles predominantly contain the processed mature insulin and 
both of these vesicles types, immature and mature, colocalise with VMAT2, 4) In β-cell cultures obtained from 
nondiabetic donors, incubation at non-stimulatory glucose concentrations promotes a shift in vesicle diameter 
towards the more mature insulin vesicles (around 300 nm) at the expense of the larger immature insulin secretory 
vesicle population. Low glucose induced vesicle maturation was not observed in the β-cell cultures obtained from 
the donor with T2D.
Transmission and scanning electron microscopy of β-cells in situ reveals about 9–13,000 secretory vesicles 
per β-cell with mature dense core vesicles having an average diameter of 300 nm33–35. In these studies, immature 
vesicles, staining less avidly with heavy metal ions (a.k.a. grey granules) have been reported but never studied 
morphometrically as detailed in this report. In our in vitro system, we found only 20–40 percent of the vesicles 
within the β-cell population in the diameter range of mature granules (≤390 nm). A second difference between 
our results and previous findings is the number of vesicles. We counted (either manually or by computer assisted 
image analysis) no more than 1,000 vesicles per cell staining for (+) DDTBZ and FluorZin-3. The simplest expla-
nation for this difference is that our lower vesicles counts are due to the smaller cell volumes encountered in 
this “flattened β-cell” culture model. In situ β-cells are estimated to have a 10 um diameter36 corresponding to a 
spherical volume of 525 µm3. The volumes of β-cells characterised in this system are better estimated by prolate 
ellipsoids with x, y and z axes of approximately 36, 12 and 0.25 µm, respectively, corresponding to a volume 
approximately one-tenth that reported for in situ β-cells. Hence, our lower vesicles counts are concordant with 
previous reports when vesicle counts are normalised to cell volume. The flattened and dissociated β-cells studied 
in this system displayed GSIS stimulation indices (S.I.) that where low (S.I. ≈ 1.3) relative to freshly isolated islets, 
yet equivalent to reports of islets that have been cultured for five days37.
In vitro human beta single cell imaging with (+) DDTBZ reveals significant heterogeneity. Single β-cell heter-
ogeneity has been previously documented for variety of outcome measures using different experimental systems 
including flow cytometry (reviewed by Nasteka and Hodson38). Most recently VMAT2 has been shown to be a 
marker of immature β-cells in cultures of induced pluripotent stem cells and its specific inhibitor, DTBZ, been 
shown to be an important regulator of β-cell maturation and β-cell mass39–41. The ability to probe heterogeneous 
populations and identify living immature β-cells by (+) DDTBZ staining may be a useful application of this 
probe.
Materials and Methods
Chemicals. Enantiomerically pure (+)-9-O-Desmethyl-α-Dihydrotetrabenazine was obtained from BOC 
Sciences, Long Island, NY and represented a convenient starting material for synthesis. All organic synthetic rea-
gents were obtained from Sigma Millipore (St. Louis, MO). Racemic Dihydrotetrabenazine (DTBZ) was obtained 
Santa Cruz Biotechnology (Santa Cruz, CA, sc-220288) All other reagents were of the highest commercially 
available quality.
Figure 9. Frequency distribution of vesicle diameters in human β-cells cultures from three donors varies 
according to culture glucose concentrations. The OpenCFU outputs of vesicle counts and diameters were 
binned (in intervals of 100 nm starting at 250 nm and ending at 2500 nm) and the frequency distribution 
histograms prepared. Automated vesicle counts ranged from 300–800 per cell, total measurements ranged from 
about 9k to 15 k vesicles per culture. Experiments performed on three different healthy donors and one donor 
diagnosed with T2D (085, 952, 585 and 184(T2D)).
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Synthesis of (+) DDTBZ. (+)-9-O-Desmethyl-α-Dihydrotetrabenazine (20 mg, 0.06 mmol) was dis-
solved in 2.5 mL dichloromethane and a catalytic amount of 4-Dimethylaminopyridine (DMAP) was added. The 
reaction was cooled to 0 °C and slowly, drop-by-drop, dansyl chloride (17.5 mg, 0.06 mmol) dissolved in 2.5 mL 
dichloromethane was added. Reaction was stirred for 2 h at 0 °C and for 24 h at room temperature. Reaction mix-
ture was concentrated under vacuum and purified using flash chromatography in 1% methanol/dichlorometh-
ane solvent system. The product 2-hydroxy-3-isobutyl-9-methoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]
isoquinolin-8-yl 5-(dimethylamino)naphthalene-1-sulfonate ((+) DDTBZ) was obtained as a yellow-green oil.
Purification and analysis of (+) DDTBZ probe. Column flash chromatography was carried out using 
E. Merck silica gel 60 F (230–400 mesh) (Sigma Millipore). The proton NMR spectra of (+) DDTBZ, recorded 
at room temperature on a Varian-NMR spectrometer, was difficult to interpret, presumably due to the presence 
of rotamers. A tentative assignment, based on the previously published spectra of tetrabenazine42, is a follows: 
1H NMR (CDCl3, 400 MHz) δ: 0.8 (6 H,m,R-CH3), 1.3–1.8 (8 H, m, R-CH2-R), 1.9 (1 H,s, R3-CH), 2.8 (6 H,m, 
RN(CH3)2), 3.2 (1 H, d, -OH), 3.8 (3 H,d,-OCH3), 6.6–8.6 (8 H, m, ArH) (referenced to internal Me4Si at δΗ 
O ppm). The high performance liquid chromatography (HPLC) system: a Shimadzu LC-6AD pump equipped 
with an SPD-M10A PDA detector was used and a single Hamilton Co. (Reno Nevada) manual injector. 
Semi-preparative chromatography was performed using SymmetryPrepTM C-18 C18 7 μm, 19 × 150 mm col-
umn, (Waters). Mobile phase details: Buffer A was composed of distilled water, and buffer B 0.25% acetic acid in 
90% acetonitrile. Purity (>96%) was confirmed by analytical LC/MS recorded with a Shimadzu system. Elution 
started with water (95%, +0.1% formic acid) and acetonitrile (5%, +0.1% formic acid) and ended with acetoni-
trile (95%, 0.1% formic acid) and water (5%, 0.1% formic acid) and used a linear gradient at a flow rate of 0.2 mL/
min.
ESI-MS spectra were obtained using a mass spectrometer Agilent ifunnel Q-TOF 6550 LC–MS with source 
Dual Agilent Jet Stream ESI (Dual AJS-ESI). The solution of the samples was directly injected into the ESI source 
using an autosampler FIA at flow rate of 1 µL min−1 at 25 °C. The solutions were eluted in a gradient of 20% 
water (0.1% formic acid) and 80% methanol (0.1% formic acid) for ESI(+) spectra. Mass spectra of the com-
pounds by ESI-MS were acquired using the following operating conditions: capillary voltage ±3 kV, drying gas 
flow 10 L min−1, drying gas at 250 °C, nebulizer gas at 50 psi. The system was operated for acquisitions in the mass 
range of 50–1500 m/z.
Characterisation of UV-Visible emission and absorption profiles of (+) DDTBZ. Absorption spec-
tra in the 250–750 nm range were recorded on a Biochrom WPA 80-3003-75 Model Biowave II UV/Visible Life 
Science Spectrophotometer. Emission spectra were recorded on a Thermoscientific Lumina Fluorescence spec-
trometer, using a 150 W Xenon Lamp and the excitation source set to the absorbance maximum of the compound 
in the 300–700 nm range. The spectral bandwidth was 5 nm, with a 2 second integration time. Data were acquired 
with Luminous software.
Cell Culture. The cell lines HEK 293, PANC1, βTC-6 and 5637 were obtained from the ATCC (Manassas, VA) 
and cultured according to the supplier’s recommendations. HEK-DAT/mCherry-VMAT2 transfectant cells were 
obtained as a kind gift from Dr. G. Miller (Emory University, Atlanta, GA) and have been fully described else-
where43. These cells were cultured at 37 °C and 5% CO2 in DMEM based selection media, supplemented with 10% 
FBS, 1% GlutaMax solution and 100 µg/ml Zeocin (In vivoGen, San Diego, CA and 500 µg/ml G418 (Millipore 
Sigma, St. Louis, MO).
Columbia University Medical Center Institutional Review Board approved human islets, isolated from 
cadaveric nondiabetic and diabetic donors, were obtained from the Integrated Islet Distribution Program (IIDP) 
(City of Hope National Medical Center). The average purity and viability of the islets obtained from control 
donors (n = 9) was 89 ± 2% and 95 ± 1% (SEM), respectively. The average age and body mass index of the donors 
was 47 ± 3 years and 32 ± 3 kg/m2 (SEM), respectively. Upon receipt, the isolated human islets were cultured in 
supplemented CMRL-1066 media for no longer than 1 day, before being subcultured as previously described15,44. 
Briefly, human islets were washed and dissociated in 0.05% Trypsin/EDTA solution. The dissociated islets were 
filtered through a sterile 40 µm nylon filter and collected and washed in minimum essential medium (MEM) with 
GlutaMAX (Gibco), 12 mM glucose, 5% FBS, 1 mM sodium, pyruvate, 10 mM HEPES, 100 U/ml Penicillin and 
100 U/ml Streptomycin and 1x B-27 Supplement (Gibco, Gaithersburg, MD). Cells were seeded at 10,000–20,000 
cells/cm2 on Collagen IV (Millipore Sigma) coated coverslip chambers (Cellvis, Mountain View, CA) in the 
same medium and allowed to reach full adherence (4–5 days) before live cell imaging or immunohistochemistry. 
Newborn porcine islets were prepared as previously described45 and processed for two dimensional culture as 
described above, with the exception that Hams F10 media was used for culture.
In some experiments, 293 HEK or HEK-DAT/mCherry-VMAT2 transfectant cells were seeded into Collagen 
IV coated coverslip chambers or sterile black 96-Well Glass Bottom Microplates (Greiner Bio-One SensoPlate) 
previously coated with poly-L-Lysine and cultured in their corresponding media to approximately 85% conflu-
ence or chambered coverslips. Cell were incubated in “imaging media” consisting of phenol-red free RPMI 1640. 
media (Caisson Labs, Smithfield, UT) supplemented with 95 mg/100 ml defatted bovine serum albumin (BSA), 
1 ml/100 ml Pen/Strep 100 x solution (Corning), 84 mg/100 mls Sodium Bicarbonate, 5 mM HEPES, and 12, 5 or 
2.5 mM Glucose) supplemented with the fluorescent probe and/or (+) DTBZ at the indicated concentrations. 
Cultures were incubated in the dark for 45 minutes at room temperature, washed twice with imaging media with-
out probes, and then incubated in probe-free imaging media for a further 30 minutes at 37 °C in a humidified 5% 
CO2 atmosphere.
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Fluorescent ligand binding experiments. Semi confluent 293 HEK or HEK-DAT mCherry-VMAT2 
transfectant cell cultures, seeded into 96 well plates, were washed once in room temperature imaging media. 
Supernatants were then replaced with imaging media supplemented with (+) DDTBZ and (+) DTBZ at the 
indicated concentration and further incubated as described above. Cell associated fluorescence measurements 
were performed on a Biotek Synergy 2 instrument, using the following parameters: (+) DDTBZ, excitation at 
320 nM with a 40 nm band pass filter, emission at 500 nm with 20 nm bandpass filter, mCherry fluorescent pro-
tein, excitation at 530 nM with a 25 nm band pass filter, emission at 590 nm with 35 nm bandpass filter. The cell 
bound fluorescence signal from DDBZ was normalised to the intensity of VMAT2-mCherry 590 nm fluorescence 
signal which served as a surrogate measure of cell number per well.
Microscopy and Live Cell Imaging. A Zeiss Axiovert 135 inverted epifluorescence microscope fitted with 
two independently controlled collimated light sources, 5.1 W Solis 385 nm LED or a 4.2 W Solis 400–700 nm 
LEDs (Thorlabs Inc., Newton, NJ) and Zeiss a 50x LD EC Epiplan-Neofluar (0.55 NA), 63 x A Plan (0.8) and 
100x Plan Neofluar (1.3 NA) objectives were used for cell imaging. Specific excitation and emission wavelengths 
where obtained with the following filter sets; A) Excitation 330WB80, Dichroic 400DCLP, Emission 495BP30 
(used for DAPI and (+) DDTBZ), B) Excitation 470QM40, Dichroic 505 DRLP, Emission 535QM50 (used for 
FluoZin-3, AM or NeuroSensor 521), C) Excitation 560QM55, Dichroic 595 DCLP, Emission 645QM75 (used 
for LysoTracker Red DND-99 and Nuclear Mask Deep Red) (all from Omega Optical, Brattleboro, VT). (+) 
DDTBZ was imaged first using the 385 nm source. The 385 nm source was then extinguished and the broadband 
400–700 nm source turned on for subsequent image acquisition. In this optical system, at 100 x magnification 
under oil, the x-y resolution was around 220 nm (given by the Abbe limit) and the depth of field of approximately 
250 nm (given by the Shillaber equation). Under these culture conditions, most β-cells could be captured in their 
entirety using a single focal plane.
Images were projected onto a Lumenera Infinity 2 monochrome 2 megapixel camera (Ottawa, Ontario, 
CA) and acquired with Lumenera Infinity Capture or IMAGEJ software. Image data was exported as single 
1392 × 1040 pixel, 16 bit grey scale TIFF files and further processed using IMAGEJ (including colocalisation scor-
ing)46, OpenCFU47 and/or Adobe Photoshop CS3. The size of objects within the images captured was obtained via 
calibration of ImageJ software with a stage micrometer (0.1 mm in 0.002 mm divisions)(Ted Pella, Inc, Redding, 
CA).
Cover glass chambered β-cell cultures were removed from the incubator and the culture media aspirated, 
washed twice with imaging media. Cultures were then incubated in imaging media (5 mM glucose) containing 30 
uM (+) DDTBZ for 45 min at room temperature, washed twice in imaging media and then incubated in imaging 
media for a further 30 minutes at 37 °C in a humidified 5% CO2 atmosphere. In the indicated experiments, prior 
to staining, β-cell cultures were preincubated in imaging media containing 12 mM glucose or 2.5 mM Glucose for 
1 hr at 37 °C, with 5% CO2. Coverslip chamber cultures were then moved to the microscope environmental cham-
ber with a temperature regulated heated stage and an objective warmer ((CSH-1 and OW, Warner Instruments, 
Hamden, CT). The cultures were maintained at 37 °C in 5% CO2 in this chamber. Cells were imaged at the indi-
cated wavelengths. In some experiments, in addition to (+) DDTBZ, cultures were also stained with 50 nM 
LysoTracker® Red DND-99 (Molecular Probes/Thermo Fisher Scientific, Waltham, MA), 2 µM FluoZin™-3, AM, 
5 µM BODIPY™ FL C5-Ceramide complexed to BSA (both from Invitrogen/Thermo Fisher Scientific, Waltham, 
MA), or 100 nM NeuroSensor 521 (Millipore Sigma). Throughout the 1–2 hour imaging session, we observed no 
signs of toxicity such as cell rounding and detachment. Identical cultures treated with reserpine (10 µM), a fluo-
rescent but irreversible VMAT2 inhibitor, showed cell rounding and detachment within 30 minutes of treatment.
Immunohistochemistry. Monolayers of pancreatic islet cells were washed in phosphate buffered saline 
(PBS) and fixed with 4% EM-grade paraformaldehyde in PFA in PBS (Electron Microscopy Sciences) at 
room temperature for 15 minutes. Samples were permeabilised in PBS + 0.3% Triton X-100 and blocked with 
PBS + 0.2% Triton X-100 with 10% goat or rabbit serum for 60 minutes at room temperature. Primary antibod-
ies (listed below) were incubated overnight at 4 °C. Alexa Fluor conjugated secondary antibodies (Invitrogen) 
were incubated in 0.3% Triton X-100 in PBS plus BSA for 60 minutes at room temperature. Coverslips were 
mounted with Vectasheild HardSet Antifade Mounting Medium with DAPI (Vector labs, Burlingame, CA). The 
following primary antibodies and dilutions were used for immunofluorescent staining: anti-Insulin rabbit mon-
oclonal antibody, 1:1000 (Boster, #M00067-1), Human/Mouse Proinsulin Alexa Fluor® 488-conjugated mouse 
monoclonal antibody, 1:200 (IC13361G) and Human VMAT2 Alexa Fluor® 594-conjugated mouse monoclonal 
antibody, 1:200 (FAB8327T) (both from R and D systems, Minneapolis, MN). A goat anti-rabbit IgG (H + L) 
cross-adsorbed secondary antibody, Alexa Fluor 430 conjugate, 1:1000 (Invitrogen, #A-11064) was used to detect 
the rabbit primary antibody above.
Glucose stimulated Insulin secretion Assays. The human beta cell cultures (prepared from two donors 
324 and 228/8 wells each) were studied on day 5 (in 12 mM Glucose) and day 7 (last two days of incubation 
in 4 mM Glucose). The cultures were washed 4 x with Krebs Buffer Solution (HEPES 25 mM, NaCl 115 mM, 
NaHCO3 24 mM, KCl 5 mM, MgCl2 1 mM, CaCl2, 2.5 mM, BSA 0.1% w/v with 2.5 mM Glucose. The culture 
chambers were next filled with 1 ml of the warmed Krebs 2.5 mM glucose solution and the cultures were incu-
bated (5% CO2) for 1 hr at 37 C degrees (similar to the protocol described for the vesicle morphometry). Next, 
the Krebs buffer solution was removed and replaced 1 ml Krebs buffer solution containing either 2.5 mM glucose 
or 16 mM Glucose and incubated again at 37 C. Sixty minutes later the Krebs buffer solution was harvested into 
labelled tubes. Residual Krebs buffer was aspirated and replaced with 250 ul of warm 5% SDS. The chambers were 
incubated for 30 min at 37 C and then the SDS solution was harvested into labelled tubes. Insulin assays were per-
formed using an ALPCO human insulin ELISA following the manufactures’ recommendations. The DNA content 
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of the well was measured using the Promega Quantitiec DNA assay following the manufactures recommenda-
tions. Aborbance and fluorescence measurements were made using the Synergy 2 multiplate reader (Biotek). The 
mean normalized insulin concentrations in the harvested Krebs buffer were calculated from replicate chambers 
and triplicate determinations of insulin concentration in the sample. Each chambers mean insulin concentration 
was normalized to the DNA content of the well.
Data analysis. Descriptive statistics, means, modes, standard deviations, standard errors as well as frequency 
distributions were calculated by Excel. Statistical significance was accepted at p values less or equal to 0.01. For 
vesicle morphometry, we used the open source program OpenCFU on a windows platform47 which outputs its 
measurements in an Excel compatible format. Images from 20–40 cells from each culture condition and donor 
were acquired with the 100 x objective and resulted in diameter measurements from about 104 vesicles from each 
human islet culture condition.
Data Availability
The datasets analysed during the current study are available from the corresponding author on reasonable re-
quest. Limited amounts of (+) DDTBZ are available from the corresponding author on request.
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